Abstract
Many human breast cancer cell lines have been in culture for several years, serving as model systems for studying aspects of breast cancer biology. Molecular alterations might occur in these cells during cultivation, and it remains unknown to which extent findings in these cell lines can be related to human disease. Hereby, we describe the establishment of a breast cancer cell line, MW1, from malignant pleural effusion. We compare expression patterns of several molecular markers in breast biopsy tissue, in cultivated tumor cells derived from pleural effusion reflecting the metastatic state, and in late passages of a lineage derived from the pleural culture.
Introduction
Most breast cancer research relies on cell lines that have been in culture for decades. While these are invaluable tools, they often drift significantly from the original human disease. There is a critical gap in our understanding of how tumor cells change as they transition from a primary site to a metastatic site (in vivo) and then adapt to the artificial environment of a plastic flask (in vitro). This study documents the evolution of the MW1 cell line, tracking which molecular features are preserved, lost, or gained as the cancer becomes more aggressive over time.
Methods
The MW1 line was derived from the pleural effusion of a 39-year-old patient with metastatic breast cancer. Researchers compared three distinct stages: the primary tumor biopsy, early passage cells (metastatic equivalent), and late passage lab-adapted cells (Clone 3) after four years of cultivation. Key techniques included Immunohistochemistry (IHC) for hormone receptors and cytokeratins, mFISH for chromosomal mapping, Western Blotting/RT-PCR for adhesion and growth factor markers, and migration assays.
Results
Morphological and Growth Evolution
During cultivation, the MW1 cells underwent significant phenotypic changes. Early-passage cells (p8-p9) exhibited complex morphology with numerous cytoplasmic projections (apophyses). Over four years of cultivation, these features were lost, and the cells (p65) adapted to a simpler adherent monolayer morphology. Parallel to these morphological changes, the growth rate increased dramatically. The doubling time decreased from approximately 79.7 hours in early passages to 38.7 hours in late passages, indicating a strong selective pressure for more rapidly dividing clones in the in vitro environment.
Molecular Metamorphosis and Marker Expression
The primary tumor was initially positive for estrogen (ER) and progesterone (PR) receptors. However, these markers were completely lost in the metastatic pleural effusion and subsequent cell line, marking a transition to a "triple-negative" phenotype. Despite this aggressive drift, the cells maintained their luminal epithelial origin, remaining positive for Cytokeratin 7 (CK 7) while negative for basal markers like CK 5/6.
Further molecular analysis revealed a "cadherin switch" where P-cadherin expression increased significantly in late passages, a hallmark of high-grade malignancy. Additionally, Integrin β4 expression, which was low in early stages, became highly expressed in the late-stage cell line.
Discussion
The establishment of the MW1 cell line provides a unique longitudinal look at tumor evolution. The observed "molecular metamorphosis"—characterized by the loss of hormone receptors, increased growth rate, and upregulation of aggressive markers like P-cadherin—highlights the selective pressures tumor cells face both in vivo and in vitro. MW1 serves as a valuable model for studying autocrine signaling loops and the role of the HGF/c-Met axis in metastasis, as the cells showed strong migratory responses to HGF.
Conclusion
This study demonstrates that breast cancer cells undergo significant molecular and phenotypic changes during the transition from primary tumor to metastasis and subsequent lab adaptation. Understanding these shifts is crucial for relating cell line research back to human disease.
Summary updated